Biomerica Inc. (BMRA)
Biomerica Statistics
Share Statistics
Biomerica has 20.37M shares outstanding. The number of shares has increased by 9.01% in one year.
| Shares Outstanding | 20.37M |
| Shares Change (YoY) | 9.01% |
| Shares Change (QoQ) | 9.01% |
| Owned by Institutions (%) | 8.21% |
| Shares Floating | 18.16M |
| Failed to Deliver (FTD) Shares | 8.55K |
| FTD / Avg. Volume | 0.99% |
Short Selling Information
The latest short interest is 186.01K, so 1.01% of the outstanding shares have been sold short.
| Short Interest | 186.01K |
| Short % of Shares Out | 1.01% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 1.02 |
Valuation Ratios
The PE ratio is -1.63 and the forward PE ratio is null. Biomerica's PEG ratio is 0.06.
| PE Ratio | -1.63 |
| Forward PE | n/a |
| PS Ratio | 1.8 |
| Forward PS | 1.7 |
| PB Ratio | 1.48 |
| P/FCF Ratio | -1.78 |
| PEG Ratio | 0.06 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Biomerica.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 0.12.
| Current Ratio | 3.51 |
| Quick Ratio | 2.43 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | -0.13 |
| Debt / FCF | -0.14 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $84.61K |
| Profits Per Employee | $-93.41K |
| Employee Count | 64 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.02 |
Taxes
| Income Tax | 42K |
| Effective Tax Rate | -0.71% |
Stock Price Statistics
The stock price has increased by -34.27% in the last 52 weeks. The beta is 0.36, so Biomerica's price volatility has been higher than the market average.
| Beta | 0.36 |
| 52-Week Price Change | -34.27% |
| 50-Day Moving Average | 0.65 |
| 200-Day Moving Average | 0.44 |
| Relative Strength Index (RSI) | 41.17 |
| Average Volume (20 Days) | 859.72K |
Income Statement
In the last 12 months, Biomerica had revenue of 5.42M and earned -5.98M in profits. Earnings per share was -0.36.
| Revenue | 5.42M |
| Gross Profit | 611K |
| Operating Income | -6.37M |
| Net Income | -5.98M |
| EBITDA | -5.99M |
| EBIT | -6.37M |
| Earnings Per Share (EPS) | -0.36 |
Balance Sheet
The company has 4.17M in cash and 785K in debt, giving a net cash position of 3.38M.
| Cash & Cash Equivalents | 4.17M |
| Total Debt | 785K |
| Net Cash | 3.38M |
| Retained Earnings | -48.2M |
| Total Assets | 7.27M |
| Working Capital | 4.07M |
Cash Flow
In the last 12 months, operating cash flow was -5.36M and capital expenditures -115K, giving a free cash flow of -5.48M.
| Operating Cash Flow | -5.36M |
| Capital Expenditures | -115K |
| Free Cash Flow | -5.48M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 11.28%, with operating and profit margins of -117.58% and -110.4%.
| Gross Margin | 11.28% |
| Operating Margin | -117.58% |
| Pretax Margin | -109.62% |
| Profit Margin | -110.4% |
| EBITDA Margin | -110.67% |
| EBIT Margin | -117.58% |
| FCF Margin | -101.13% |
Dividends & Yields
BMRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for BMRA.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Apr 21, 2025. It was a backward split with a ratio of 1:8.
| Last Split Date | Apr 21, 2025 |
| Split Type | backward |
| Split Ratio | 1:8 |
Scores
| Altman Z-Score | -8.17 |
| Piotroski F-Score | 3 |